Subscribe Become an Author Log In

BiopharmaTrend.com

Decisions supported by knowledge

Pharmaceutical industry trends


Hot Research (Investment) Topics in Drug Discovery - 2019

   by Andrii Buvailo    241
Hot Research (Investment) Topics in Drug Discovery - 2019

Things like gene editing, stem cells, immunotherapies and new types of biologics are now mega-trends in the pharmaceutical industry, widely covered in media, and I guess there is little doubt that biology is the next big thing in medicine. However, in this post I would like to outline several hot areas in small molecule drug discovery, suggesting a lot of untapped potential and investment prospects in this more “traditional” pharmaceutical research space.

Healthcare Information Technology (IT) Market to See 15.4% Growth to Hit US$441.8 Billion by 2025

   by Global Market Insights    215
Healthcare Information Technology (IT) Market to See 15.4% Growth to Hit US$441.8 Billion by 2025

According to a new research report by the market research and strategy consulting firm, Global Market Insights, Inc, the Healthcare Information Technology (IT) Market worth over $441.8bn by 2025. Favorable government initiatives for encouraging adoption of information technology in healthcare services will boost industry growth in the future. For instance, the U.S. government passed the Health Information Technology for Economic and Clinical Health (HITECH) Act, providing funds worth USD 20 billion for setting up electronic health records. Such government initiatives should propel the Healthcare IT market growth.

Big Investments for Human Microbiome Research

   by Tim Sandle    514
Big Investments for Human Microbiome Research

Major companies on the scene include Second Genome, Enterome, and EpiBiome. In addition, several new startups have entered the field. Amongst the most active investors, Global Engage reports, are Seventure Partners, Flagship Pioneering and BioGaia. In fact there are some 120 companies investing in analyzing data relating to the human microbiome. To take one example, companies such as uBiome are developing genomic tests meant to identify and diagnose harmful microbes in the body.

Confluence of Technologies Can Bring “Virtual Pharmacology” to the Next Level

   by Andrii Buvailo    1087
Confluence of Technologies Can Bring “Virtual Pharmacology” to the Next Level

In 1970-80s, the idea of virtual screening was regarded as a conceptual way to substitute costly and time-consuming experimental “screen-everything-you-have” approaches with a much faster and cheaper predictive modelling to cherry-pick only the best molecules for subsequent synthesis and validation in a lab. A great number of computational tools and approaches emerged, aiming at “pre-screening” new promising molecules, so called “hits”, or augmenting experimental screening programs to optimize efforts.